Subdermal Contraceptive Implants Market Growth $1,245.79 Mn By 2032 CAGR 4.3%

Subdermal Contraceptive Implants Market Size Worth $ 1,245.79 Million By 2032 | CAGR: 4.3%

The global subdermal contraceptive implants market size is expected to reach USD 1,245.79 million by 2032, according to a new study by Polaris Market Research. The report “Subdermal Contraceptive Implants Market Share, Size, Trends, Industry Analysis Report, By Product (Levonorgestrel Implant, Etonogestrel Implant, Others); By Implant; By End-Use; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Subdermal Contraceptive Implants Market is for contraceptive implants inserted under the skin to prevent pregnancy. Subdermal contraceptive implants are small, flexible devices that release hormones into the body to provide long-term contraception. These implants are usually placed in the upper arm and can provide effective birth control for several years.

The market includes subdermal contraceptive implants, such as those containing progestin hormones. The growing awareness about family planning and the increasing demand for long-acting reversible contraception methods drive the growth of the subdermal contraceptive implants market.

The demand for subdermal contraceptive implants is steadily increasing due to highly effective and long-acting contraceptive solutions for women, offering protection against unintended pregnancies for several years. This convenience and reliability make them a preferred choice for many women who desire long-term contraception.

Also, subdermal contraceptive implants offer a reversible form of contraception. Once the implant is removed, fertility can be restored relatively quickly, allowing women to plan their pregnancies according to their preferences.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

Furthermore, subdermal contraceptive implants are discreet and require minimal user involvement after insertion. It suits women with difficulty adhering to daily or frequent contraceptive methods such as pills or injections.

The scope of the subdermal contraceptive implants market is expanding as more healthcare providers and organizations promote and advocate for long-acting reversible contraception options. Government initiatives and programs focused on family planning and reproductive health also contribute to the growing demand for subdermal contraceptive implants.

Additionally, technological advancements and the development of new implant designs further enhance the market scope. Manufacturers are continuously improving the efficacy, safety, and ease of use of subdermal contraceptive implants, making them more appealing to a wider range of women.

Subdermal Contraceptive Implants Market Report Highlights

  • In 2023, the Levonorgestrel Implant segment held the largest subdermal contraceptive implants market share due to its high effectiveness, long-lasting protection (3 to 5 years), and user convenience.
  • The hospital segment expected to witness the fastest CAGR during forecast period due to the advanced healthcare infrastructure, high-traffic environment, advanced medical services, equipment availability, and experienced medical professionals. These factors collectively support the growth of this segment by providing convenience, quality care, and patient confidence.
  • In 2023, North America accounted for the largest market, due to the increasing number of registered abortions in North America fueled market growth, highlighting the need for effective contraceptive options. Increasing health concerns, a rising number of unwanted pregnancies, and increasing awareness about efficient contraceptives, including affordable implants, drove the demand in the region.
  • The main market companies in the subdermal contraceptives industry include Mayer Laboratories, Bayer AGKESSEL meantime GmbH, Teva Pharmaceutical Industries Ltd., Shanghai Dahua Pharmaceutical Co., Ltd., Allergan plc, Reckitt Benckiser Group plc, The Female Health Company, Merck & Co., Inc., and Karex Industries.

Polaris Market Research has segmented the subdermal contraceptive implants market report based on products, end-use, implant, and region:

Subdermal Contraceptive Implants, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Levonorgestrel Implant
  • Etonogestrel Implant

Subdermal Contraceptive Implants, Implant Outlook (Revenue - USD Million, 2019 - 2032)

  • single rod
  • Two-rod

Subdermal Contraceptive Implants, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Clinics
  • Others

Subdermal Contraceptive Implants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Subdermal Contraceptive Implants Market Report Scope

Report Attributes


Market size value in 2024

USD 886.84 million

Revenue forecast in 2032

USD 1,245.79 million


4.3% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD million and CAGR from 2024 to 2032

Segments Covered

By Products, By Implant, By End-Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation.

For Specific Research Requirements

Request for Customized Report